Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31498242 | 1.00 | MGAM (0.61) | MGAMALDH1A1HPGDGLAMAPT | |
| SCHEMBL15778250 | 0.89 | MGAM (0.61) | MGAMALDH1A1HPGDGLAMAPT | |
| SCHEMBL9051022 | 0.89 | MGAM (0.56) | MGAMALDH1A1HPGDGLAMAPT | |
| SCHEMBL27739759 | 0.87 | ALDH1A1 (0.58) | MGAMALDH1A1HPGDGLAMAPT | |
| Acridine SCHEMBL29143509 | 0.86 | ALDH1A1 (0.62) | MGAMALDH1A1HPGDGLAMAPT | |
| Acridine SCHEMBL9644821 | 0.86 | ALDH1A1 (0.62) | MGAMALDH1A1HPGDGLAMAPT | |
| SCHEMBL9095415 | 0.86 | ALDH1A1 (0.52) | MGAMALDH1A1HPGDGLAMAPT | |
| SCHEMBL3636462 | 0.84 | ALDH1A1 (0.54) | MGAMALDH1A1HPGDGLAMAPT | |
| SCHEMBL29519324 | 0.84 | MAPT (0.54) | MGAMALDH1A1HPGDGLAMAPT | |
| SCHEMBL27418511 | 0.84 | MAPT (0.54) | MGAMALDH1A1HPGDGLAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115627083-B | Preparation method of nano calcium carbonate for asphalt system | 广西民泰纳米科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-112939960-B | Carbonyl azetidine substituted NBD fluorescent dye and synthetic method and application thereof | 中国科学院大连化学物理研究所 | 2023-04-14 | — | — | CN | claimed |
| CN-115627083-A | Preparation method of nano calcium carbonate for asphalt system | 广西民泰纳米科技有限公司 | 2023-01-20 | — | — | CN | claimed |
| CN-113718256-B | Copper etching liquid and application thereof in wafer level packaging | 浙江奥首材料科技有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-113718256-A | Copper etching liquid and application thereof in wafer level packaging | 浙江奥首材料科技有限公司 | 2021-11-30 | — | — | CN | claimed |
| CN-104961213-B | A kind of remove the water treatment agent of organochlorine pesticide in water | 章俊 | 2016-10-05 | — | — | CN | claimed |
| CN-105038184-A | Preparation method for automobile sealing strip | ZHANG LIZHEN | 2015-11-11 | — | — | CN | claimed |
| CN-104961213-A | Water treating agent for removing organo-chlorine pesticides in water | JIN SHUANGLEI | 2015-10-07 | — | — | CN | claimed |
| CN-104962068-A | Anti-corrosion wear-resisting anti-aging automobile sealing strip | ZHANG LIZHEN | 2015-10-07 | — | — | CN | claimed |
| CN-104891626-A | Water treatment chemical for removing aniline compounds in water | JIN SHUANGLEI | 2015-09-09 | — | — | CN | claimed |
| CN-104891624-A | Water treatment chemical for removing chlorobenzene compounds in water | JIN SHUANGLEI | 2015-09-09 | — | — | CN | claimed |
| US-20250346585-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| CN-119219669-A | Compound capable of degrading KRAS and application of compound in medicine | 西藏海思科制药有限公司 | 2024-12-31 | — | — | CN | disclosed |
| US-11981753-B2 | Peptide compound and application thereof, and composition containing peptide compound | SHANGPHARMA INNOVATION INC. (US) | 2024-05-14 | — | — | US | disclosed |
| CN-115627083-B | Preparation method of nano calcium carbonate for asphalt system | 广西民泰纳米科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| US-5874441-A | TREATMENT OF AUTOIMMUNE DISEASES, INFLAMMATION | DUPONT PHARMACEUTICALS COMPANY (US) | 1999-02-23 | — | — | US | disclosed |
| WO-1998017650-A1 | BIS(ACRIDINECARBOXAMIDE) AND BIS(PHENAZINECARBOXAMIDE) AS ANTITUMOUR AGENTS | XENOVA LIMITED (GB) | 1998-04-30 | — | — | WO | disclosed |
| CN-1180349-A | Compounds, compositions and methods for generating chemiluminescence by reaction with phosphatases | LUMIGEN INC (US) | 1998-04-29 | — | — | CN | disclosed |
| EP-0819119-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN, INC. (US) | 1998-01-21 | — | — | EP | disclosed |
| WO-1997026245-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN, INC. (US) | 1997-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11981753-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, NPY1R, GLP1R | MGAM 3170/4885ALDH1A1 4788/4885HPGD 3976/4885 |
| US-20250346585-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | C5, C1S, C9 | MGAM 1512/4885ALDH1A1 1707/4885HPGD 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.